← Leaderboards
Yongrong Zhang
University Of South Florida
$471,371
Attributed
$942,741
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $701.9K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$942,741 · 2
By mechanism
R01$511,553 · 1
R21$431,188 · 1
Top collaborators
- Xingmin Sun2 shared
- Hanping Feng1 shared
Most similar at University Of South Florida
Same institution · by research overlap
- Liwang Cui$22,085,389
- Jianfeng Cai$10,262,045
- Michael J. Barber$1,048,934
- Patrick Christopher Bradshaw$570,106
- Jun Miao$823,500
Others in their field
Other Rising Stars on “Prevent”
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Melissa Basford · Vanderbilt University Medical Center$37,410,924
- David Annett · Information Management Services, Inc.$34,721,865
- Christina Millin · Rho Federal Systems Division, Inc.$31,828,916
- Lee Lichtenstein · Vanderbilt University Medical Center$26,108,724
- Dorota A. Grejner-Brzezinska · University Of Wisconsin-Madison$19,883,568
Research focus
PreventPseudomembranous ColitisGut MicrobiotaPlayProbioticsProteinsEngineered ProbioticsEngineeringLeadOral AdministrationPreventionBiological Response Modifier TherapyAnimal ModelCaspaseAntibodiesDysbiosisAnti-ToxinCenters For Disease Control And Prevention (U.S.)ImmunotherapyInfectionLifeClostridium DifficileAntibioticsRecurrence
Grant awards (3)
Development of Oral Immunotherapy against Clostridioides difficile Transmission$511,553
R01 · FY2025 · AI · contact PI
Development of probiotic-based and Clostridioides difficile-targeted therapeutics$190,313
R21 · FY2025 · AI
Development of probiotic-based and Clostridioides difficile-targeted therapeutics$240,875
R21 · FY2024 · AI